About Us
History
Facilities
Who We Are
Our commitment
Capability
Why us
Industrialize Your Products
Quality & Regulatory
GMP Devices
Scientific Services
Plasmids & RNA
Recombinant Virus
CRO services
Off-the-shelf Products
Support
CDMO Solutions
CDMO Service
Facilities
Innovation
Life&Health CDMO
Insights
Press Releases
Events
Contact us
FAQ
About Us
History
Facilities
SPIRO Site
OBiO Intelli-M
Who We Are
Our commitment
Capability
Why us
Industrialize Your Products
Quality & Regulatory
GMP Devices
Scientific Services
Plasmids & RNA
Plasmids
Mimics & siRNA
Recombinant Virus
Adeno-associated Virus
Adenovirus
Lentivirus
Retrovirus
Herpes Simplex Virus
CRO services
AAV capsid discovery
CRISPR Library Services
Stable Cell Line
Cell experimental services
Animal experimental services
Off-the-shelf Products
AAV tools
Support
FAQ
Citations
Brochures & Flyers
CDMO Solutions
CDMO Service
Facilities
Innovation
Life&Health CDMO
Insights
Press Releases
Events
Contact us
FAQ
Home
>
Scientific Services
>
Support
>
FAQ
>
FAQ
2026-04-13
How can the appropriate antibiotic concentration for screening stable cell lines be determined? Is it necessary to continuously add antibiotics throughout the stable strain culture process?
2026-04-13
If exogenous gene expression is undetectable , what should be done?
2026-04-13
What are the differences between siRNA and shRNA? How should the groups be arranged for conventional interference detection?
2026-04-13
Can Lentivirus be employed as conventional plasmids for overexpression?
2026-04-13
Will the target protein invariably be upregulated or downregulated following overexpression or knocking down of the target gene?
2026-04-10
How should frozen sections be stored?
2026-04-10
What is the difference between siRNA and shRNA?
2026-04-10
When it is necessary to observe with small animal imaging, is it better to carry a fluorescent protein gene or a luciferase gene in AAV?
2026-04-10
Why can't the target antibody detect overexpression or knockdown effects after AAV infects animals?
«
1
2
»
Request Now
About Us
History
Facilities
Who We Are
Our commitment
Capability
Why us
Industrialize Your Products
Quality & Regulatory
GMP Devices
Scientific Services
Plasmids & RNA
Recombinant Virus
CRO services
Off-the-shelf Products
Support
CDMO Solutions
CDMO Service
Facilities
Innovation
Life&Health CDMO
Insights
Press Releases
Events
Contact us
© OBiO Tech, Inc. All Rights Reserved